Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome

Recurrence of primary disease is one of the major risks for allograft loss after pediatric RTx. The risk of recurrence of FSGS/SRNS after pediatric RTx in particular can be up to 86% in idiopathic cases. There is a need for consensus recommendations on its prevention and treatment. The CERTAIN study group has therefore performed a thorough literature search based on the PICO model of clinical questions to formulate educated statements to guide the clinician in the process of decision‐making. A set of educated statements on prevention and treatment of FSGS/SRNS after pediatric RTx has been generated after careful evaluation of available evidence and thorough panel discussion. We do not recommend routine nephrectomy prior to transplantation; neither do we recommend abstaining from living donation. Special attendance needs to be given to those patients who had already experienced graft loss due to FSGS/SRNS recurrence. Early PE or IA with or without high‐dose CsA and/or rituximab seems to be most promising to induce remission. The educated statements presented here acknowledge that FSGS/SRNS recurrence after pediatric RTx remains a major concern and is associated with shorter graft survival or even graft loss. The value of any recommendation needs to take into account that evidence is based on cohorts that differ in ethnicity, pre‐transplant history, immunosuppressive regimen, definition of recurrence (eg, clinical and/or histological diagnosis) and treatment modalities of recurrence.

[1]  J. Dantal,et al.  Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation , 2020, Pediatric Nephrology.

[2]  T. Bunchman,et al.  Dextran-Sulfate Plasma Adsorption Lipoprotein Apheresis in Drug Resistant Primary Focal Segmental Glomerulosclerosis Patients: Results From a Prospective, Multicenter, Single-Arm Intervention Study , 2019, Front. Pediatr..

[3]  F. Camassei,et al.  Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis , 2019, Pediatric Nephrology.

[4]  G. Mayer,et al.  Immunoadsorption in nephrotic syndrome: Where are we now and where are we going from here? , 2019, Atherosclerosis. Supplements.

[5]  T. Blydt-Hansen,et al.  Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis , 2019, Pediatric transplantation.

[6]  D. Hooper,et al.  LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients , 2019, Pediatric Nephrology.

[7]  R. Grenda,et al.  Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions. , 2018, Transplantation proceedings.

[8]  Karan R. Kumar,et al.  Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings , 2018, Pediatric Nephrology.

[9]  R. Salomon,et al.  Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  B. Chavers,et al.  The effect of peri‐transplant plasmapheresis in the prevention of recurrent FSGS , 2018, Pediatric transplantation.

[11]  Graham M Lord,et al.  Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. , 2017, Kidney international.

[12]  G. Canaud,et al.  Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes , 2017, Transplantation.

[13]  T. Seeman,et al.  Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. , 2016, Minerva pediatrica.

[14]  R. Grenda,et al.  Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome , 2016, European Journal of Pediatrics.

[15]  H. Cheong,et al.  Recurrence and Treatment after Renal Transplantation in Children with FSGS , 2016, BioMed research international.

[16]  M. Pronicki,et al.  Fatal rituximab‐associated lung injury syndrome in a patient treated with rituximab for recurrence of post‐transplant nephrotic syndrome , 2015, Pediatric transplantation.

[17]  A. Anarat,et al.  Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[18]  T. Seeman.  Management of proteinuria in the transplanted patient , 2015, Pediatric Nephrology.

[19]  C. Antignac,et al.  Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. , 2014, Journal of the American Society of Nephrology : JASN.

[20]  S. Florman,et al.  Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients , 2014, Pediatric transplantation.

[21]  J. Goebel,et al.  Focal Segmental Glomerulosclerosis in Children: Multivariate Analysis Indicates That Donor Type Does Not Alter Recurrence Risk , 2013, Transplantation.

[22]  H. Asanuma,et al.  Combination of pulse methylprednisolone infusions with cyclosporine‐based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation , 2013, Clinical transplantation.

[23]  R. Ettenger,et al.  Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation , 2011, Pediatric transplantation.

[24]  R. Grenda,et al.  Long‐term effect of rituximab in maintaining remission of recurrent and plasmapheresis‐dependent nephrotic syndrome post‐renal transplantation – Case report , 2010, Pediatric transplantation.

[25]  P. Waber,et al.  Recurrence of focal segmental glomerulosclerosis in renal allograft: An in‐depth review , 2010, Pediatric transplantation.

[26]  芳充 後藤.  海外論文紹介 : Strict Blood-Pressure Control and Progression of Renal Failure in Children , 2010 .

[27]  R. Camilla,et al.  Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation , 2009, Transplantation.

[28]  T. Larson,et al.  Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis: Outcomes and Response to Therapy for Recurrence , 2009, Transplantation.

[29]  F. Hildebrandt,et al.  Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life. , 2009, Kidney international.

[30]  B. Ranchin,et al.  Disease recurrence in paediatric renal transplantation , 2009, Pediatric Nephrology.

[31]  A. Bella,et al.  Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function , 2009, Clinical transplantation.

[32]  M. del Río,et al.  Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: A single center experience , 2008, Pediatric transplantation.

[33]  G. Mayer,et al.  [Primary glomerulonephritis]. , 2006, Wiener klinische Wochenschrift.

[34]  B. Tönshoff,et al.  Recurrence of Focal-Segmental Glomerulosclerosis in Children after Renal Transplantation: Clinical and Genetic Aspects , 2005, Transplantation.

[35]  Y. Ishikawa,et al.  Post‐transplant early recurrent proteinuria in patients with focal glomerulosclerosis‐ Angiotensin II immunostaining and treatment outcome , 2005, Clinical transplantation.

[36]  G. Ciancio,et al.  Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience , 2005, Pediatric Nephrology.

[37]  M. Baum.  Outcomes after renal transplantation for FSGS in children , 2004, Pediatric transplantation.

[38]  L. Travis,et al.  High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  D. Gipson,et al.  The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  M. Seikaly.  Recurrence of primary disease in children after renal transplantation: An evidence‐based update , 2004, Pediatric transplantation.

[41]  P. Niaudet,et al.  Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome , 1994, Pediatric Nephrology.

[42]  A. Kassir,et al.  Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide , 1993, Pediatric Nephrology.

[43]  R. Salomon,et al.  Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children , 2003, Transplantation.

[44]  D. Stablein,et al.  North American Pediatric Renal Transplant Cooperative Study , 2003 .

[45]  D. Stablein,et al.  Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis , 2002, Pediatric transplantation.

[46]  Julian de Meyrick,et al.  The Delphi method and health research , 2003 .

[47]  M. Fujisawa,et al.  Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation , 2002, Pediatric Nephrology.

[48]  H. Cheong,et al.  Recurrent focal segmental glomerulosclerosis following renal transplantation in Korean pediatric patients , 2001, Pediatric transplantation.

[49]  D. Stablein,et al.  Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. , 2001, Kidney international.

[50]  L. Travis,et al.  Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis , 2000, Pediatric Nephrology.

[51]  S. Kim,et al.  Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  G. Ghiggeri,et al.  Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  R. J. Unwin,et al.  Kidney , 1969, The Journal of physiology.

[54]  S. Knechtle,et al.  The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. , 1996, Transplantation.

[55]  A. Sedman,et al.  Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide. , 1994, Clinical transplantation.

[56]  A. Tejani,et al.  Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. , 1992, Journal of the American Society of Nephrology : JASN.

[57]  P. Beighton,et al.  Clinical and Genetic Aspects , 1980 .